Clinical Trials Browser

Phase NA × Withdrawn × Celecoxib × Clear all

NCT00084370 2013-08-22

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Phase NA Withdrawn

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00084578 2013-07-15

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Phase NA Withdrawn

Urinary Bladder Neoplasms